CM-352   Click here for help

GtoPdb Ligand ID: 8259

Synonyms: compound 2 [PMID 25686022] [2]
Compound class: Synthetic organic
Comment: CM-352 is an optimized matrix metalloproteinase (MMP) inhibitor which inhibits fibrinolysis, and represents a novel type of antihaemorrhagic agent [2].
PubChem CID 72720906 represents the molecule without the stereochemistry attributed in [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 4
Rotatable bonds 8
Topological polar surface area 142.21
Molecular weight 487.18
XLogP 1.73
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES ONC(=O)C1(CCC2(C1)CCNCC2)S(=O)(=O)c1ccc(cc1)Oc1ccc(cc1)C(=O)NC
Isomeric SMILES ONC(=O)[C@]1(CCC2(C1)CCNCC2)S(=O)(=O)c1ccc(cc1)Oc1ccc(cc1)C(=O)NC
InChI InChI=1S/C24H29N3O6S/c1-25-21(28)17-2-4-18(5-3-17)33-19-6-8-20(9-7-19)34(31,32)24(22(29)27-30)11-10-23(16-24)12-14-26-15-13-23/h2-9,26,30H,10-16H2,1H3,(H,25,28)(H,27,29)/t24-/m1/s1
InChI Key ZUZGJCNWNOCKEB-XMMPIXPASA-N
References
1. Orbe J, Barrenetxe J, Rodriguez JA, Vivien D, Orset C, Parks WC, Birkland TP, Serrano R, Purroy A, Martinez de Lizarrondo S et al.. (2011)
Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism.
Circulation, 124 (25): 2909-19. [PMID:22104553]
2. Orbe J, Rodríguez JA, Sánchez-Arias JA, Salicio A, Belzunce M, Ugarte A, Chang HC, Rabal O, Oyarzabal J, Páramo JA. (2015)
Discovery and safety profiling of a potent preclinical candidate, (4-[4-[[(3R)-3-(hydroxycarbamoyl)-8-azaspiro[4.5]decan-3-yl]sulfonyl]phenoxy]-N-methylbenzamide) (CM-352), for the prevention and treatment of hemorrhage.
J Med Chem, 58 (7): 2941-57. [PMID:25686022]
3. Rodríguez JA, Sobrino T, Orbe J, Purroy A, Martínez-Vila E, Castillo J, Páramo JA. (2013)
proMetalloproteinase-10 is associated with brain damage and clinical outcome in acute ischemic stroke.
J Thromb Haemost, 11 (8): 1464-73. [PMID:23742289]
4. Suzuki Y, Nagai N, Umemura K, Collen D, Lijnen HR. (2007)
Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice.
J Thromb Haemost, 5 (8): 1732-9. [PMID:17596135]